Controlled Catheter Movement Affects Dye Dispersal Volume in Agarose Gel Brain Phantoms

Jason N Mehta1, Gabrielle R McRoberts2, Christopher G Rylander1

  • 1Walker Department of Mechanical Engineering, The University of Texas at Austin, 204 E. Dean Keeton Street, Stop C2200, Austin, TX 78712-1591, USA.

Pharmaceutics
|August 16, 2020
PubMed

Insights

Controlled catheter movement during convection-enhanced delivery (CED) can improve drug dispersal for glioblastoma treatment. Continuous retraction of the catheter significantly increased dye dispersal volume in brain phantom models.

Area of Science:

  • Neurosurgery
  • Biomedical Engineering
  • Oncology

Background:

  • Glioblastoma treatment has a poor prognosis, with standard care offering limited survival benefits.
  • Convection-enhanced delivery (CED) is an investigational locoregional therapy for glioblastoma, delivering drugs directly into brain tissue.
  • Current CED clinical trials face challenges due to inadequate tumor coverage with standard stationary catheters.

Purpose of the Study:

  • To investigate the impact of controlled catheter movement on drug dispersal volume in glioblastoma treatment.
  • To compare the efficacy of different catheter movement protocols (stationary, continuous retraction, continuous insertion, intermittent insertion) on infusion parameters.

Main Methods:

  • Utilized a single-port stepped catheter with intrainfusion movement capabilities in agarose gel brain tissue phantoms.
  • Applied four distinct catheter movement protocols: stationary, continuous retraction, continuous insertion, and intermittent insertion.
  • Infused indigo carmine dye and quantified dispersal volume (Vd), forward dispersal volume (Vdf), infusion radius, backflow, and forward flow using optical imaging.

Main Results:

  • Retraction and intermittent insertion protocols resulted in significantly larger dispersal volumes (Vd and Vdf) compared to the stationary protocol.
  • The stationary catheter group exhibited a larger infusion radius but also greater backflow and reduced forward flow.
  • Continuous catheter retraction during CED demonstrated potential for enhanced drug distribution over traditional stationary methods.

Conclusions:

  • Continuous catheter retraction during CED may improve glioblastoma treatment outcomes by increasing drug dispersal volume.
  • Catheter design is critical for preventing infusate backflow along the needle tract, which can negatively impact dispersal.
  • Optimizing catheter movement strategies holds promise for enhancing the effectiveness of convection-enhanced delivery for brain tumors.